Developmental neurotoxicity (DNT): A call for implementation of new approach methodologies for regulatory purposes: Summary of the 5th International Conference on DNT Testing
Celardo, Ivana Aschner, Michael Ashton, Randolph S Carstens, Kelly E Cediel-Ulloa, Andrea Cöllen, Eike Crofton, Kevin M Debad, Susan J Dreser, Nadine Fitzpatrick, Suzanne
Celardo, Ivana
Aschner, Michael
Ashton, Randolph S
Carstens, Kelly E
Cediel-Ulloa, Andrea
Cöllen, Eike
Crofton, Kevin M
Debad, Susan J
Dreser, Nadine
Fitzpatrick, Suzanne
Series / Report no.
Open Access
Type
Journal Article
Congress
Article
Congress
Article
Language
en
Date of publication
2025
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
Developmental neurotoxicity (DNT): A call for implementation of new approach methodologies for regulatory purposes: Summary of the 5th International Conference on DNT Testing
Translated Title
Published in
ALTEX 2025; 42(2):323-49
Abstract
The 5th International Conference on Developmental Neurotoxicity (DNT) Testing (DNT5) took place in April 2024 in Konstanz, Germany, organized by CAAT-Europe, the University of Konstanz, and scientists from the US EPA, SCAHT, and CAAT at Johns Hopkins University Bloomberg School of Public Health. The conference convened experts from regulatory agencies, industry, and academia to explore the latest advancements in DNT testing and the integration of animal-free new approach methodologies (NAMs) into next-generation risk assessment (NGRA). The key topic was the appli-cation and further development of the recently established DNT in vitro test battery (DNT-IVB). To support this, OECD held a satellite meeting to discuss necessary next steps for further implementation of the DNT-IVB in regulatory contexts. Validation of new DNT test methods and use of their data for in-vitro-to-in-vivo extrapolations in physiologically based kinetic models were also important themes of the main meeting. In this context, the question was raised when a comprehensive biological and chemical coverage by the DNT-IVB would be reached. A need for additional testing data was recognized. Context-specific validation approaches for the entire DNT-IVB and the potential for intelligent combinations of assays to enhance the predictive power of the test battery were also addressed. Many presentations demonstrated the field's embrace of novel developments, including the use of multi-endpoint embryonic zebrafish tests, the development of artificial intelligence-driven computational approaches, and the establishment of complex, electrically active brain organoids and other self-organizing structures. Through its highly interactive format, DNT5 promoted extensive collaborative efforts in advancing the field toward more human-relevant, scientifically reliable, and ethical toxicological assessments.
The 5th International Conference on Developmental Neurotoxicity (DNT) Testing (DNT5) took place in April 2024 in Konstanz, Germany. Experts from regulatory agencies, industry, and academia convened to discuss how best to integrate animal-free new approach methodologies (NAMs) into next-generation risk assessment. The key topic was the application and further development of the recently established DNT in vitro test battery (DNT-IVB). The use of data from the DNT-IVB was a central theme. For instance, it was discussed how data from cell culture methods could be used to predict safe human exposures. Moreover, the conference addressed the need for comprehensive biological and chemical coverage by the DNT-IVB. Many presentations demonstrated the field’s embrace of novel developments, including the use of multi-endpoint embryonic zebrafish tests, the development of artificial intelligence-driven computational approaches, and the establishment of complex, electrically active brain organoids and other self-organizing structures.
The 5th International Conference on Developmental Neurotoxicity (DNT) Testing (DNT5) took place in April 2024 in Konstanz, Germany. Experts from regulatory agencies, industry, and academia convened to discuss how best to integrate animal-free new approach methodologies (NAMs) into next-generation risk assessment. The key topic was the application and further development of the recently established DNT in vitro test battery (DNT-IVB). The use of data from the DNT-IVB was a central theme. For instance, it was discussed how data from cell culture methods could be used to predict safe human exposures. Moreover, the conference addressed the need for comprehensive biological and chemical coverage by the DNT-IVB. Many presentations demonstrated the field’s embrace of novel developments, including the use of multi-endpoint embryonic zebrafish tests, the development of artificial intelligence-driven computational approaches, and the establishment of complex, electrically active brain organoids and other self-organizing structures.